What Happened?
Princeton, NJ-based Vividion Therapeutics Appointed Stan Blackburn Stan as Principal
About the Company
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company`s cutting-edge platform was spun out of the labs of Vividion`s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
About the Person
Stan Blackburn Stan is Principal at Vividion Therapeutics. Previously, Stan Blackburn held various senior HR leadership roles in the industry.
Info Source
News
Short Profile